Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H29FN4O2 |
Molecular Weight | 400.4897 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=CC2=C1C(O)CCN(CCCN3CCN(CC3)C4=CC=C(F)C=C4)C2=O
InChI
InChIKey=KBZUFSZQLVRGPR-UHFFFAOYSA-N
InChI=1S/C22H29FN4O2/c1-24-11-7-19-21(24)20(28)8-12-27(22(19)29)10-2-9-25-13-15-26(16-14-25)18-5-3-17(23)4-6-18/h3-7,11,20,28H,2,8-10,12-16H2,1H3
Molecular Formula | C22H29FN4O2 |
Molecular Weight | 400.4897 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:29:57 GMT 2023
by
admin
on
Sat Dec 16 11:29:57 GMT 2023
|
Record UNII |
LEV29G9Q9T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9952825
Created by
admin on Sat Dec 16 11:29:57 GMT 2023 , Edited by admin on Sat Dec 16 11:29:57 GMT 2023
|
PRIMARY | |||
|
LEV29G9Q9T
Created by
admin on Sat Dec 16 11:29:57 GMT 2023 , Edited by admin on Sat Dec 16 11:29:57 GMT 2023
|
PRIMARY | |||
|
191592-09-3
Created by
admin on Sat Dec 16 11:29:57 GMT 2023 , Edited by admin on Sat Dec 16 11:29:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
Mechanism of Action Alpha 1 adrenergic receptor agonists
Serotonin receptor antagonists, 18 Jun 2002 Discontinued - Phase-II for Arterial occlusive disorders in Japan (PO)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
SUN C5174: Alternative Names - SUN C 5174, Mechanism of Action - Alpha 1 adrenergic receptor agonists, Serotonin receptor antagonists, 18 Jun 2002 Discontinued - Phase-II for Arterial occlusive disorders in Japan (PO)
|